“Cost-Effectiveness Analysis of Alirocumab in High Cardiovascular-Risk Patients in Italy”. Farmeconomia. Health Economics and Therapeutic Pathways, vol. 22, no. 1, June 2021, https://doi.org/10.7175/fe.v22i1.1499.